COMP <GO>
ENSG vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY
The Ensign Group Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ENSG 5
— JNJ 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: JNJ
LAST: $181.52 (-2.58%) • MKT CAP: $10.87B
balance-sheet
3.73
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | 67.90% | -47.80 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 25.50% | -7.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 18.5x | -1.50 | ENSG | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 2.97% | +0.14 | ENSG | /fcf-yield <GO> |
| Operating Margin | 8.50% | 34.70% | -26.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 6.80% | 28.50% | -21.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 6.00% | +12.80 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 0.00% | +0.13 | ENSG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.73 | 5.59 | -1.86 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.20% | -0.70 | ENSG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 60.4 | -4.41 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.08 | -0.19 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 23.0x | +3.50 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.87B | $662.49B | -$651.62B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | JNJ REV | ENSG GROSS % | JNJ GROSS % | ENSG FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $94.19B | 20.1% | 67.9% | $337.8M | $19.70B |
| FY 2024 | $4.24B | $88.82B | 20.3% | 69.1% | $156.5M | $19.84B |
| FY 2023 | $3.71B | $85.16B | 44.0% | 44.0% | $209.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
JNJ // BETA 1.08